These research findings present new perspectives and approaches to treating adolescent depression, indicating that by regulating the expression level of HMGB1, it may be possible to significantly improve depressive symptoms in patients, bringing new breakthroughs to clinical treatment of depression. This evidence concerns the gene HMGB1 and major depressive disorder.